<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="style.css">
    <link rel="stylesheet" href="https://maxst.icons8.com/vue-static/landings/line-awesome/line-awesome/1.3.0/css/line-awesome.min.css">
    <title>DERMA World</title>
</head>
<header>

    <div class="topnav">
        <div class="logo">
            <img src="img/logo.png" alt="DERMA World by LEO Pharma logo">
        </div>
        <div class="search-wrapper">
            <input type="search" placeholder="SEARCH"/>
            <span class="las la-search"></span> 
        </div>
        <button class="burger-menu"></button>
    </div>

    <div class="navbar">
        <div class="subnav">
            <button class="subnavbtn">Bedingungen<i class="fa fa-caret-down"></i></button>
            <div class="subnav-content">
            </div>
        </div> 
        <div class="subnav">
          <button class="subnavbtn">Behandlungen</button>
          <div class="subnav-content">
            <a class="sub-subnavbtn">Adtralza</a>
                <div class="sub-subnav-content">
                    <a href="#">Overview</a>
                    <a href="#">Overview</a>
                    <a href="#">Mode of Action</a>
                    <a href="#">Efficacy</a>
                    <a href="#">Quality of Life</a>
                    <a href="#">Safety</a>
                    <a href="#">Dosing</a>
                    <a href="#">News</a>
                    <a href="#">Technical Information</a> 
                </div>
            <a href="#">Diavonex</a>
            <a href="#">Diavobet</a>
            <a href="#">Enstilar</a>
            <a href="#">Fucidin</a>
            <a href="#">Kyntheum</a>
            <a href="#">Protopic</a>
            <a href="#">Skinoren</a>
            <a href="#">Tralokinumab</a>
            <a href="#">Xamiol</a>
          </div>
        </div> 
        <div class="subnav">
          <button class="subnavbtn">Veranstaltungen<i class="fa fa-caret-down"></i></button>
          <div class="subnav-content">
          </div>
        </div> 
        <div class="subnav">
          <button class="subnavbtn">Werkzeuge<i class="fa fa-caret-down"></i></button>
          <div class="subnav-content">
          </div>
        </div> 
        <div class="subnav">
          <button class="subnavbtn">Forschung und Erkenntnisse<i class="fa fa-caret-down"></i></button>
          <div class="subnav-content">
          </div>
        </div>  
      </div>
    
    </header>
    <body>

        <main>
            <!-- Hero section -->
            <section class="container hero-section">
                <div class="overlay"></div>
                <div class="text">
                    <img src="img/adtralza.png" alt="Adtralza logo">
                    <h2>Adtralza® is a new treatment for adult patients with moderate-to-severe atopic dermatitis (eczema) who are candidates for systemic therapy.</h2>
                </div>
                <img src="img/hero.png" alt="Women with eczema">
            </section>

            <!-- 2. Section: Introducing the medication -->
            <section class="container second-section">
                <div class="visual">
                    <img src="img/adtralza-packshot-gebaut-01 2.png" alt="Adtralza drug">
                </div>
                <div class="text">
                    <h2>It is the first and only biologic developed to specifically neutralize IL-13, a key driver of atopic dermatitis signs and symptoms(1,2)</h2>
                    <p>Learn more about how Adtralza® works and how to use it in treatment.</p>
                </div>
            </section>

            <!-- 3. Section: Adavntages of the Adtralza medication -->
            <section class="container advantages third-section">
                <div class="advantage">
                    <div class="visual"><img src="img/icon-long-term.png" alt="Long term improvement"></div>
                    <div class="text">
                        <h3>Long term sustained improvement</h3>
                        <p>9 out of 10 respondents experienced sustained disease control in clinical trials 10, providing sustained improvements in the burden of disease(1,2, 1, 8*†‡).</p>
                        <a href="#">See efficacy and trial data</a>
                    </div>
                </div>
                <div class="advantage">
                    <div class="visual">
                        <img src="img/icon-improvements.png" alt="Improvements in the burden of disease">
                    </div>
                    <div class="text">
                        <h3>Improvements in the burden of disease</h3>
                        <p>Patients in clinical trials saw an improvement in Quality of Life with early symptom relief and sustained improvements in burden of disease from week 16 to 32(12,13).</p>
                        <a href="#">Learn more about quality of life improvements</a>
                    </div>
                </div>
                <div class="advantage">
                    <div class="visual">
                        <img src="img/icon-safety.png" alt="Safety profile">
                    </div>
                    <div class="text">
                        <h3>Good safety profile</h3>
                        <p>The overall frequency and severity of adverse events with Adtralza® were comparable to placebo at 16 weeks* and 52 weeks(19).</p>
                        <a href="#">See safety profile</a>
                    </div>
                </div>
            </section>
            <section class="container fourth-section">
                <div class="text">
                    <h2>Adtralza® neutralizes IL-13, a key driver of Atopic Dermatitis signs and symptoms.</h2>
                    <p>By specifically targeting the IL-13 cytokine, Adtralza® inhibits the interaction with type II receptors and prevents IL-13-induced inflammatory responses in the skin(1,2).
    
                        Adtralza® selectively modulates the dysregulated immune system by(1): 
                        
                        — Reducing markers of skin inflammation 
                        — Improving markers of skin barrier integrity 
                        — Reducing epidermal thickness</p>
                    <button href="#">Watch the video</button>
                    <sub>Duration:   2:43</sub>
                </div>
                <div class="visual">
                    <img src="img/cytokine-illustration.png" alt="Adtralza and how it works">
                </div>
            </section>

            <section class="container fifth-section">
                <h2>Clinical tools - at a glance</h2>
                <div class="guides-container">
                    <div class="guide">
                        <img src="img/dosing-guide.png" alt="Adtralza dosing guide ">
                        <div class="text">
                            <h2>Dosing guide</h2>
                            <p>Adtralza® has a straightforward dosing regimen, with 150 mg prefilled syringes(1). </p>
                            <a href="#">Learn more about application and dosing</a>
                        </div>
                    </div>
                    <div class="guide">
                        <img src="img/injection.png" alt="Adtralza injection guide">
                        <div class="text">
                            <h2>Patient injection made simple</h2>
                            <p>This step by step video guide shows the patient how to self inject using the two syringes that come in the Adtralza® carton.</p>
                            <a href="#">Watch the video</a>
                        </div>
                    </div>
                </div>
            </section>
        </main>
        

        <footer>
            <div class="visual">
                <img src="img/LEO logo.png" alt="LEO logo">
            </div>
            <div class="footer-links">
                <a href="#">Contact</a>
                <a href="#">Imprint</a>
                <a href="#">Conditions</a>
                <a href="#">Terms of use</a>
                <a href="#">Privary</a>
                <a href="#">Cookie content</a>
            </div>
                    <div class="copyright-text">
                    <p>© Copyright LEO Pharma 2020
                        LEO and the LEO Lion Design
                        are registered trademarks
                        of LEO Pharma<br>
                        All rights reserved</p>
    
                        <a href="#">
                            LEO Pharma corporate website
                        </a>
            </div>
        </footer>
        
    </body>
</html>